Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny G. Peter; Lynn S. Zijenah; Duncan Chanda; Petra Clowes; Maia Lesosky; Phindile Gina; Nirja Mehta; Greg Calligaro; Carl J. Lombard; Gerard Kadzirange; Tsitsi Bandason; Abidan Chansa; Namakando Liusha; Chacha Mangu; Bariki Mtafya; Henry Msila; Andrea Rachow; Michael Hoelscher; Peter Mwaba; Grant Theron; Keertan Dheda

doi:10.1016/s0140-6736(15)01092-2

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

Jonny G. Peter
, Lynn S. Zijenah
, Duncan Chanda
, Petra Clowes
, Maia Lesosky
, Phindile Gina
, Nirja Mehta
, Greg Calligaro
, Carl J. Lombard
, Gerard Kadzirange
, Tsitsi Bandason
, Abidan Chansa
, Namakando Liusha
, Chacha Mangu
, Bariki Mtafya
, Henry Msila
, Andrea Rachow
, Michael Hoelscher
, Peter Mwaba
, Grant Theron

Keertan Dheda

University of Cape Town
University of Zimbabwe
University Teaching Hospital Lusaka
National Institute for Medical Research Tanzania
Ludwig Maximilian University of Munich
Biomedical Research and Training Institute
German Center for Infection Research, Munich Partner Site
Stellenbosch University

Research output: Contribution to journal › Article › peer-review

229 Citations (Scopus)

Original language	English
Pages (from-to)	1187-1197
Number of pages	11
Journal	The Lancet
Volume	387
Issue number	10024
DOIs	https://doi.org/10.1016/s0140-6736(15)01092-2
Publication status	Published - 19 Mar 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/s0140-6736(15)01092-2

Cite this

Peter, J. G., Zijenah, L. S., Chanda, D., Clowes, P., Lesosky, M., Gina, P., Mehta, N., Calligaro, G., Lombard, C. J., Kadzirange, G., Bandason, T., Chansa, A., Liusha, N., Mangu, C., Mtafya, B., Msila, H., Rachow, A., Hoelscher, M., Mwaba, P., ... Dheda, K. (2016). Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. The Lancet, 387(10024), 1187-1197. https://doi.org/10.1016/s0140-6736(15)01092-2

@article{9c726e3a1f1e49e7a40c4c672b59ecdb,

title = "Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial",

author = "Peter, \{Jonny G.\} and Zijenah, \{Lynn S.\} and Duncan Chanda and Petra Clowes and Maia Lesosky and Phindile Gina and Nirja Mehta and Greg Calligaro and Lombard, \{Carl J.\} and Gerard Kadzirange and Tsitsi Bandason and Abidan Chansa and Namakando Liusha and Chacha Mangu and Bariki Mtafya and Henry Msila and Andrea Rachow and Michael Hoelscher and Peter Mwaba and Grant Theron and Keertan Dheda",

year = "2016",

month = mar,

day = "19",

doi = "10.1016/s0140-6736(15)01092-2",

language = "English",

volume = "387",

pages = "1187--1197",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10024",

}

Peter, JG, Zijenah, LS, Chanda, D, Clowes, P, Lesosky, M, Gina, P, Mehta, N, Calligaro, G, Lombard, CJ, Kadzirange, G, Bandason, T, Chansa, A, Liusha, N, Mangu, C, Mtafya, B, Msila, H, Rachow, A, Hoelscher, M, Mwaba, P, Theron, G & Dheda, K 2016, 'Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial', The Lancet, vol. 387, no. 10024, pp. 1187-1197. https://doi.org/10.1016/s0140-6736(15)01092-2

Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. / Peter, Jonny G.; Zijenah, Lynn S.; Chanda, Duncan et al.
In: The Lancet, Vol. 387, No. 10024, 19.03.2016, p. 1187-1197.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial

AU - Peter, Jonny G.

AU - Zijenah, Lynn S.

AU - Chanda, Duncan

AU - Clowes, Petra

AU - Lesosky, Maia

AU - Gina, Phindile

AU - Mehta, Nirja

AU - Calligaro, Greg

AU - Lombard, Carl J.

AU - Kadzirange, Gerard

AU - Bandason, Tsitsi

AU - Chansa, Abidan

AU - Liusha, Namakando

AU - Mangu, Chacha

AU - Mtafya, Bariki

AU - Msila, Henry

AU - Rachow, Andrea

AU - Hoelscher, Michael

AU - Mwaba, Peter

AU - Theron, Grant

AU - Dheda, Keertan

PY - 2016/3/19

Y1 - 2016/3/19

U2 - 10.1016/s0140-6736(15)01092-2

DO - 10.1016/s0140-6736(15)01092-2

M3 - Article

SN - 0140-6736

VL - 387

SP - 1187

EP - 1197

JO - The Lancet

JF - The Lancet

IS - 10024

ER -

Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. The Lancet. 2016 Mar 19;387(10024):1187-1197. doi: 10.1016/s0140-6736(15)01092-2